Sarcoma Survival Rates

Sarcoma is a rare and varied group of cancers that develop in the body's connective tissues: bone, muscle, fat, blood vessels, nerves, and other supportive tissue. Because there are more than 70 recognized subtypes, "sarcoma" statistics can vary a lot depending on where the cancer starts and how it's classified.

A note before you read on: These are population-level statistics, not individual predictions. Your own outlook depends on your specific sarcoma subtype, grade, location, and stage. These numbers are meant to inform a conversation with your oncologist — not replace one.

How Common Is Sarcoma?

Sarcomas are rare in adults, making up about 1% of all adult cancer diagnoses. In the U.S. in 2026, an estimated 13,910 new soft tissue sarcomas and 4,110 new bone sarcomas will be diagnosed, with around 7,610 deaths expected from these diseases combined.

A few things that make sarcoma statistics unusual compared to most cancers:

• Sarcoma is relatively more common in children. Between 1,500 and 1,700 children in the U.S. are diagnosed with a bone or soft tissue sarcoma each year, accounting for roughly 15% of all childhood cancers, a much larger share than in adults.

• There are two broad categories: soft tissue sarcomas (about 80% of cases, arising in muscle, fat, nerves, and blood vessels) and bone sarcomas (about 20%, including osteosarcoma, chondrosarcoma, and Ewing sarcoma).

• Location matters. Sarcomas most commonly develop in the arms, legs, chest, and abdomen, though they can technically occur almost anywhere in the body.

What Is the Survival Rate for Sarcoma?

Survival rates differ significantly depending on whether the sarcoma started in soft tissue or bone, and how far it has spread at diagnosis.      

Soft tissue sarcoma — 5-year relative survival by stage:

Bone sarcoma has an overall 5-year relative survival rate of roughly 83%, though, as with soft tissue sarcoma, this varies by specific subtype (osteosarcoma, chondrosarcoma, Ewing sarcoma, chordoma, and others each behave differently) and by stage at diagnosis.

The clearest pattern across nearly every study: catching sarcoma before it spreads is the single biggest factor in long-term survival. Localized disease carries survival rates roughly 4–5 times higher than metastatic disease.

Is Sarcoma Curable?

For many patients, particularly those diagnosed with localized, non-metastatic disease, yes. Surgery is the cornerstone of sarcoma treatment, with the goal of completely removing the tumor while preserving as much normal function as possible. Modern limb-sparing surgical techniques now successfully avoid amputation in about 95% of extremity sarcoma cases, a major shift from older treatment approaches.

Sarcoma that has spread to distant sites (metastatic disease) is harder to cure, but it isn't hopeless: newer immunotherapy and targeted treatment options are improving outcomes for advanced disease, and some patients with limited metastases (for example, a small number of tumors in the lungs) have achieved remission through a combination of surgery and systemic therapy.

How Long Will I Live? Putting the Numbers in Context

A few things are worth understanding about what these survival numbers can and can't tell you:

• Subtype matters enormously. With 70+ recognized sarcoma subtypes, behavior and prognosis vary widely — some grow slowly and respond well to treatment, while others are more aggressive.

• Stage at diagnosis is the strongest single predictor. The difference between localized and metastatic disease is roughly a 4–5x difference in 5-year survival.

• Survival tends to stabilize after 5 years. Research suggests patients who reach the 5-year mark often maintain similar survival rates out to 10 years, suggesting many achieve durable, long-term remission rather than late recurrence.

• Even stage 4 isn't a fixed outcome. Roughly 17% of metastatic sarcoma patients survive 5 years, and that number is expected to keep improving as newer treatments become more widely available.

Because sarcoma is so varied, the most useful next step is a conversation with an oncologist experienced in sarcoma specifically, ideally at a specialized sarcoma treatment center, who can weigh your exact subtype, grade, and stage rather than relying on the averages alone.

Sources

• American Cancer Society, Key Statistics for Soft Tissue Sarcoma and Survival Rates for Soft Tissue Sarcomas — cancer.org

• American Cancer Society / SEER, 2026 estimates via Cancer Statistics Center— seer.cancer.gov 

• Sarcoma Foundation of America, 2026 Sarcoma Statistics — curesarcoma.org

• National Foundation for Cancer Research, Sarcoma Cancer overview — nfcr.org

• SEER Cancer Statistics Explorer (Soft Tissue & Bone Cancer) — seer.cancer.gov